Baird’s Experts Examine Today’s Robust Healthcare Markets
As a preview to Baird’s 2015 Healthcare Conference, several of the firm’s senior experts weighed in on the ever-evolving Healthcare sector. Explore the content below for insights on current trends, deal activity and areas to watch in the balance of 2015.
Baird Equity Research explores key topics in Healthcare IT: the impact of ongoing regulatory uncertainty, what's driving M&A in the sector and the rise of consumerism within healthcare.
Despite sky-high valuations, investors continue to converge on Healthcare IT, and this wave of activity is driving development in communication, care and solutions.
Biotech crossover investments are on the rise, boosting IPO valuations and returns for investors. Baird believes this trend will continue to drive deal activity, shape investors’ expectations, and inform issuers’ decisions on financial matters and deal timing.
While the whole industry may be benefiting, Baird says public players are being rewarded with higher valuations.
Baird delivers a comprehensive, integrated Healthcare platform to institutional and corporate clients.